{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:32:59Z","timestamp":1790371979886,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T00:00:00Z","timestamp":1730160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T00:00:00Z","timestamp":1730160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-024-03532-w","type":"journal-article","created":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T16:02:43Z","timestamp":1730217763000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["A multidimensional analysis of the impact of obesity on immune checkpoint inhibitor therapy efficacy"],"prefix":"10.1186","volume":"24","author":[{"given":"Wenjing","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengwen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,29]]},"reference":[{"key":"3532_CR1","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1146\/annurev-pathol-042020-042741","volume":"16","author":"S Bagchi","year":"2021","unstructured":"Bagchi S, Yuan R, Engleman EG. Immune checkpoint inhibitors for the treatment of cancer: clinical impact and mechanisms of response and resistance. Ann Rev Pathol. 2021;16:223.","journal-title":"Ann Rev Pathol"},{"issue":"9","key":"3532_CR2","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/S1470-2045(17)30422-9","volume":"18","author":"MJ Overman","year":"2017","unstructured":"Overman MJ, McDermott R, Leach Jl, et al. Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study. Lancet Oncol. 2017;18(9):1182.","journal-title":"Lancet Oncol"},{"issue":"4","key":"3532_CR3","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1056\/NEJMoa1412082","volume":"372","author":"C Robert","year":"2015","unstructured":"Robert C, Long GV, Brady B, et al. Nivolumab in previously untreated melanoma without BRAF mutation. N Engl J Med. 2015;372(4):320\u201330.","journal-title":"N Engl J Med"},{"key":"3532_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-019-0805-8","author":"S Das","year":"2019","unstructured":"Das S, Johnson DB. Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors. J Immunother Cancer. 2019. https:\/\/doi.org\/10.1186\/s40425-019-0805-8.","journal-title":"J Immunother Cancer"},{"key":"3532_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17981-0","author":"A Casrto","year":"2020","unstructured":"Casrto A, Pyke RM, Zhang X, et al. Strength of immune selection in tumors varies with sex and age. Nat Commun. 2020. https:\/\/doi.org\/10.1038\/s41467-020-17981-0.","journal-title":"Nat Commun"},{"issue":"6","key":"3532_CR6","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/S1470-2045(18)30261-4","volume":"19","author":"F Conforti","year":"2018","unstructured":"Conforti F, Pala L, Bagnardi V, et al. Cancer immunotherapy efficacy and patients\u2019 sex: a systematic review and meta-analysis. Lancet Oncol. 2018;19(6):737\u201346.","journal-title":"Lancet Oncol"},{"key":"3532_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.107923","volume":"229","author":"L Desharnais","year":"2022","unstructured":"Desharnais L, Walsh LA, Quail DF. Exploiting the obesity-associated immune microenvironment for cancer therapeutics. Pharmacol Ther. 2022;229: 107923.","journal-title":"Pharmacol Ther"},{"issue":"5","key":"3532_CR8","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.10002","volume":"6","author":"HA Loomans-Kropp","year":"2023","unstructured":"Loomans-Kropp HA, Umar A. Analysis of body mass index in early and middle adulthood and estimated risk of gastrointestinal cancer. JAMA Netw Open. 2023;6(5): e2310002.","journal-title":"JAMA Netw Open"},{"issue":"19","key":"3532_CR9","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1200\/JCO.2012.48.4691","volume":"31","author":"CM Kitahara","year":"2013","unstructured":"Kitahara CM, Berndt SI, De Gonz\u00e1lez AB, et al. Prospective investigation of body mass index, colorectal adenoma, and colorectal cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. J Clin Oncol. 2013;31(19):2450\u20139.","journal-title":"J Clin Oncol"},{"issue":"7","key":"3532_CR10","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1111\/jgh.15364","volume":"36","author":"JM Moon","year":"2021","unstructured":"Moon JM, Im JP, Kim D, et al. Increasing changes in visceral adiposity is associated with higher risk for colorectal adenoma: multilevel analysis in a prospective cohort. J Gastroenterol Hepatol. 2021;36(7):1836\u201342.","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"3532_CR11","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1210\/endrev\/bnad015","volume":"44","author":"KA Brown","year":"2023","unstructured":"Brown KA, Scherer PE. Update on adipose tissue and cancer. Endocrine Rev. 2023;44(6):961.","journal-title":"Endocrine Rev"},{"issue":"7","key":"3532_CR12","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1016\/j.cell.2020.11.009","volume":"183","author":"AE Ringel","year":"2020","unstructured":"Ringel AE, Drijvers JM, Baker GJ, et al. Obesity shapes metabolism in the tumor microenvironment to suppress anti-tumor immunity. Cell. 2020;183(7):1848.","journal-title":"Cell"},{"issue":"8","key":"3532_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005226","volume":"10","author":"JH Lee","year":"2022","unstructured":"Lee JH, Hyung S, Lee J, et al. Visceral adiposity and systemic inflammation in the obesity paradox in patients with unresectable or metastatic melanoma undergoing immune checkpoint inhibitor therapy: a retrospective cohort study. J Immunother Cancer. 2022;10(8): e005226.","journal-title":"J Immunother Cancer"},{"issue":"23","key":"3532_CR14","doi-asserted-by":"publisher","first-page":"5180","DOI":"10.1158\/1078-0432.CCR-22-1389","volume":"28","author":"Y Ged","year":"2022","unstructured":"Ged Y, Sanchez A, Patil S, et al. Associations between pretreatment body composition features and clinical outcomes among patients with metastatic clear cell renal cell carcinoma treated with immune checkpoint blockade. Clin Cancer Res. 2022;28(23):5180\u20139.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"3532_CR15","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/jamaoncol.2019.5241","volume":"6","author":"G Kichenadasse","year":"2020","unstructured":"Kichenadasse G, Miners JO, Mangoni AA, et al. association between body mass index and overall survival with immune checkpoint inhibitor therapy for advanced non-small cell lung cancer. JAMA Oncol. 2020;6(4):512\u20138.","journal-title":"JAMA Oncol"},{"issue":"6","key":"3532_CR16","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1002\/jcsm.13367","volume":"14","author":"JH Lee","year":"2023","unstructured":"Lee JH, Kang D, Ahn JS, et al. Obesity paradox in patients with non-small cell lung cancer undergoing immune checkpoint inhibitor therapy. J Cachexia Sarcopenia Muscle. 2023;14(6):2898\u2013907.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"3532_CR17","doi-asserted-by":"publisher","first-page":"111345","DOI":"10.1016\/j.nut.2021.111345","volume":"90","author":"HY Deng","year":"2021","unstructured":"Deng HY, Chen ZJ, Qiu XM, et al. Sarcopenia and prognosis of advanced cancer patients receiving immune checkpoint inhibitors: a comprehensive systematic review and meta-analysis. Nutrition. 2021;90:111345.","journal-title":"Nutrition"},{"issue":"1","key":"3532_CR18","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/j.1467-789X.2009.00623.x","volume":"11","author":"MM Ibrahim","year":"2010","unstructured":"Ibrahim MM. Subcutaneous and visceral adipose tissue: structural and functional differences. Obesity Rev. 2010;11(1):118.","journal-title":"Obesity Rev"},{"issue":"4","key":"3532_CR19","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1007\/s00125-006-0173-z","volume":"49","author":"CA Curat","year":"2006","unstructured":"Curat CA, Wegner V, Sengen\u00e8s C, et al. Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin. Diabetologia. 2006;49(4):744\u20137.","journal-title":"Diabetologia"},{"key":"3532_CR20","doi-asserted-by":"publisher","first-page":"1228076","DOI":"10.3389\/fonc.2023.1228076","volume":"13","author":"K Heshmat-Ghahdarijani","year":"2023","unstructured":"Heshmat-Ghahdarijani K, Sarmadi V, Heidari A, et al. The neutrophil-to-lymphocyte ratio as a new prognostic factor in cancers: a narrative review. Front Oncol. 2023;13:1228076.","journal-title":"Front Oncol"},{"key":"3532_CR21","unstructured":"Pacific W H O R O For The W. The Asia-Pacific perspective\u202f: redefining obesity and its treatment. Sydney\u202f: Health Communications Australia, 2000."},{"issue":"1","key":"3532_CR22","first-page":"24","volume":"64","author":"ER Barbalho","year":"2020","unstructured":"Barbalho ER, Rocha IM, Medeiros GO, et al. Agreement between software programmes of body composition analyses on abdominal computed tomography scans of obese adults. Archiv Endocrinol Metabol. 2020;64(1):24.","journal-title":"Archiv Endocrinol Metabol"},{"key":"3532_CR23","first-page":"e61674","volume":"169","author":"S Steele","year":"2021","unstructured":"Steele S, Lin F, Le TL, et al. Segmentation and linear measurement for body composition analysis using slice-o-matic and horos. J Vis Exp. 2021;169:e61674.","journal-title":"J Vis Exp"},{"issue":"20","key":"3532_CR24","doi-asserted-by":"publisher","first-page":"5028","DOI":"10.1158\/1078-0432.CCR-18-0788","volume":"24","author":"J Lee","year":"2018","unstructured":"Lee J, Chang CL, Lin JB, et al. Skeletal muscle loss is an imaging biomarker of outcome after definitive chemoradiotherapy for locally advanced cervical cancer. Clin Cancer Res. 2018;24(20):5028\u201336.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"3532_CR25","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1002\/jcsm.12797","volume":"12","author":"X Zeng","year":"2021","unstructured":"Zeng X, Shi Z, Yu J, et al. Sarcopenia as a prognostic predictor of liver cirrhosis: a multicentre study in China. J Cachexia Sarcopenia Muscle. 2021;12(6):1948\u201358.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"10","key":"3532_CR26","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nri.2016.90","volume":"16","author":"SL Klein","year":"2016","unstructured":"Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16(10):626\u201338.","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"3532_CR27","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.ccell.2022.06.005","volume":"40","author":"L Pala","year":"2022","unstructured":"Pala L, De Pas T, Catania C, et al. Sex and cancer immunotherapy: current understanding and challenges. Cancer Cell. 2022;40(7):695\u2013700.","journal-title":"Cancer Cell"},{"key":"3532_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.102057","volume":"91","author":"F-M Zhang","year":"2023","unstructured":"Zhang F-M, Wu H-F, Shi H-P, et al. Sarcopenia and malignancies: epidemiology, clinical classification and implication. Ageing Res Rev. 2023;91: 102057.","journal-title":"Ageing Res Rev"},{"issue":"9","key":"3532_CR29","doi-asserted-by":"publisher","first-page":"6426","DOI":"10.1007\/s00330-023-09524-0","volume":"33","author":"A Surov","year":"2023","unstructured":"Surov A, Strobel A, Borggrefe J, et al. Low skeletal muscle mass predicts treatment response in oncology: a meta-analysis. Eur Radiol. 2023;33(9):6426\u201337.","journal-title":"Eur Radiol"},{"issue":"1","key":"3532_CR30","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41591-018-0221-5","volume":"25","author":"Z Wang","year":"2019","unstructured":"Wang Z, Aguilar EG, Luna JI, et al. Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade. Nat Med. 2019;25(1):141.","journal-title":"Nat Med"},{"issue":"2","key":"3532_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jitc-2020-000725","volume":"8","author":"SK Boi","year":"2020","unstructured":"Boi SK, Orlandella RM, Gibson JT, et al. Obesity diminishes response to PD-1-based immunotherapies in renal cancer. J Immunother Cancer. 2020;8(2):1.","journal-title":"J Immunother Cancer"},{"issue":"18","key":"3532_CR32","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3390\/molecules24183214","volume":"24","author":"S Wang","year":"2019","unstructured":"Wang S, Cowley LA, Liu XS. sex differences in cancer immunotherapy efficacy, biomarkers, and therapeutic strategy. Molecules. 2019;24(18):141.","journal-title":"Molecules"},{"issue":"3","key":"3532_CR33","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/S1470-2045(18)30078-0","volume":"19","author":"JL McQuade","year":"2018","unstructured":"McQuade JL, Daniel CR, Hess KR, et al. Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis. Lancet Oncol. 2018;19(3):310.","journal-title":"Lancet Oncol"},{"issue":"23","key":"3532_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/JCI151347","volume":"131","author":"B Chakraborty","year":"2021","unstructured":"Chakraborty B, Byemerwa J, Shepherd J, et al. Inhibition of estrogen signaling in myeloid cells increases tumor immunity in melanoma. J Clin Investig. 2021;131(23):1.","journal-title":"J Clin Investig"},{"key":"3532_CR35","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.mce.2014.11.029","volume":"1","author":"BF Palmer","year":"2015","unstructured":"Palmer BF, Clegg DJ. The sexual dimorphism of obesity. Mol Cell Endocrinol. 2015;1:113.","journal-title":"Mol Cell Endocrinol"},{"issue":"5","key":"3532_CR36","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/s41590-023-01479-0","volume":"24","author":"T Chavakis","year":"2023","unstructured":"Chavakis T, Alexaki VI, Ferrante AW Jr. Macrophage function in adipose tissue homeostasis and metabolic inflammation. Nat Immunol. 2023;24(5):757.","journal-title":"Nat Immunol"},{"issue":"12","key":"3532_CR37","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1172\/JCI200319246","volume":"112","author":"SP Weisberg","year":"2003","unstructured":"Weisberg SP, McCann D, Desai M, et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Investig. 2003;112(12):1796.","journal-title":"J Clin Investig"},{"issue":"8","key":"3532_CR38","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1038\/s41590-022-01267-2","volume":"23","author":"A Christofides","year":"2022","unstructured":"Christofides A, Strauss L, Yeo A, et al. The complex role of tumor-infiltrating macrophages. Nat Immunol. 2022;23(8):1148.","journal-title":"Nat Immunol"},{"issue":"2","key":"3532_CR39","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.it.2020.12.001","volume":"42","author":"A Robinson","year":"2021","unstructured":"Robinson A, Han CZ, Glass CK, et al. Monocyte regulation in homeostasis and malignancy. Trends Immunol. 2021;42(2):104.","journal-title":"Trends Immunol"},{"issue":"1","key":"3532_CR40","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1172\/JCI29881","volume":"117","author":"CN Lumeng","year":"2007","unstructured":"Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Investig. 2007;117(1):175\u201384.","journal-title":"J Clin Investig"},{"issue":"12","key":"3532_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109285","volume":"35","author":"AK Pingili","year":"2021","unstructured":"Pingili AK, Chaib M, Sipe LM, et al. Immune checkpoint blockade reprograms systemic immune landscape and tumor microenvironment in obesity-associated breast cancer. Cell Rep. 2021;35(12): 109285.","journal-title":"Cell Rep"},{"issue":"7","key":"3532_CR42","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1016\/j.cell.2023.02.032","volume":"186","author":"J Gungabeesoon","year":"2023","unstructured":"Gungabeesoon J, Gort-Freitas NA, Kiss M, et al. A neutrophil response linked to tumor control in immunotherapy. Cell. 2023;186(7):1448\u20131464.e20.","journal-title":"Cell"},{"issue":"8","key":"3532_CR43","doi-asserted-by":"publisher","first-page":"14381","DOI":"10.1038\/ncomms14381","volume":"1","author":"J Kargl","year":"2017","unstructured":"Kargl J, Busch SE, Yang GH, et al. Neutrophils dominate the immune cell composition in non-small cell lung cancer. Nat Commun. 2017;1(8):14381.","journal-title":"Nat Commun"},{"issue":"10","key":"3532_CR44","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41571-019-0222-4","volume":"16","author":"ME Shaul","year":"2019","unstructured":"Shaul ME, Fridlender ZG. Tumour-associated neutrophils in patients with cancer. Nat Rev Clin Oncol. 2019;16(10):601\u201320.","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"3532_CR45","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.celrep.2014.12.039","volume":"10","author":"JY Sagiv","year":"2015","unstructured":"Sagiv JY, Michaeli J, Assi S, et al. Phenotypic diversity and plasticity in circulating neutrophil subpopulations in cancer. Cell reports. 2015;10(4):154.","journal-title":"Cell reports"},{"issue":"5","key":"3532_CR46","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.immuni.2019.03.009","volume":"50","author":"R Zilionis","year":"2019","unstructured":"Zilionis R, Engblom C, Pfirschke C, et al. Single-cell transcriptomics of human and mouse lung cancers reveals conserved myeloid populations across individuals and species. Immunity. 2019;50(5):1317.","journal-title":"Immunity"},{"issue":"24","key":"3532_CR47","first-page":"00012","volume":"S1550\u20134131","author":"Y Lai","year":"2024","unstructured":"Lai Y, Gao Y, Lin J, et al. Dietary elaidic acid boosts tumoral antigen presentation and cancer immunity via ACSL5. Cell Metab. 2024;S1550\u20134131(24):00012\u20133.","journal-title":"Cell Metab"},{"issue":"15","key":"3532_CR48","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1200\/JCO.23.00225","volume":"41","author":"M Merino","year":"2023","unstructured":"Merino M, Kasamon Y, Theoret M, et al. Irreconcilable differences: the divorce between response rates, progression-free survival, and overall survival. J Clin Oncol. 2023;41(15):2706.","journal-title":"J Clin Oncol"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-024-03532-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-024-03532-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-024-03532-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T17:02:15Z","timestamp":1730221335000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerci.biomedcentral.com\/articles\/10.1186\/s12935-024-03532-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,29]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3532"],"URL":"https:\/\/doi.org\/10.1186\/s12935-024-03532-w","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,29]]},"assertion":[{"value":"12 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in accordance with the Helsinki standard and the study\u2019s protocol was approved by Guangdong Provincial People\u2019s Hospital Research Ethics Committee (ref No: KY2023-714\u201301).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"358"}}